INSMED INC Inventory
INSMED INC (INSM) had Inventory of $142.38 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2026-08-06
- 2026-06-30: Inventory, Net $142.38M.
- 2026-03-31: Inventory, Net $132.91M.
- 2025-12-31: Inventory, Net $132.07M.
- 2025-09-30: Inventory, Net $120.97M.
| Period end | Inventory, Net |
|---|---|
| 2026-06-30 | $142.38M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $132.91M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $132.07M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $120.97M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $107.61M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $100.71M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $98.58M 10-K · filed 2026-02-19 |
| 2024-09-30 | $98.47M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $90.06M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $82.96M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $83.25M 10-K · filed 2025-02-20 |
| 2023-09-30 | $77.92M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $77.35M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $71.32M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $69.92M 10-K · filed 2024-02-22 |
| 2022-09-30 | $66.28M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $67.02M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $64.14M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $67.01M 10-K · filed 2023-02-23 |
| 2021-09-30 | $67.45M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $60.38M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $52.06M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $49.59M 10-K · filed 2022-02-17 |
| 2020-09-30 | $43.48M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $35.47M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $30.64M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $28.31M 10-K · filed 2021-02-25 |
| 2019-09-30 | $23.31M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $20.16M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $12.68M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $7.03M 10-K · filed 2020-02-25 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |